2016 Canadian Conference on Ovarian Cancer Research: Intensify Innovation, Improve Impact

Louise Brinton

Incidence of Cancer in Women after Treatment with IVF

Ovary Melanoma of skin Corpus uteri Colorectum Cervix uteri Breast

A New Analytical Paradigm to Predict and Prevent Bladder Toxicity from Pelvic Radiation Therapy

Testis Ovary Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast

Radiation Oncology

Kunle O Odunsi

RPCI-UPCI Ovarian Cancer SPORE

Ovary

Mary Anne Rossing

Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer

Ovary

Pathology

Christopher I Li

Breast and Ovary Cancer Clinical Validation Center

Ovary Breast

Sohrab Shah

The clonal dynamics of ovarian cancers: phylogenetic models of chemosensitivity and resistance

Ovary

Pathology

Joanne F Dorgan

Prospective Study of Serum MIS and Gynecologic Cancer Risk

Ovary Corpus uteri

Scott H Kaufmann

Mayo Clinic SPORE in Ovarian Cancer

Ovary

Pathology

Norman Wolmark

NRG Oncology Network Group Operations Center

Trachea, bronchus and lung Stomach Prostate Pancreas Ovary Oesophagus Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Corpus uteri Colorectum Cervix uteri Breast Brain, nervous system Bladder

Radiation Oncology Surgery / Surgical oncology